SCHEMBL3170044

SCHEMBL3170044

[CH]=CC(CC)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5153732 0.77
SCHEMBL1402217 0.71
SCHEMBL4967668 0.69
SCHEMBL270568 0.69
SCHEMBL4620857 0.69
SCHEMBL3061436 0.69
SCHEMBL276883 0.69
SCHEMBL14211014 0.69
SCHEMBL21332317 0.67
SCHEMBL23058 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4402948-A HEMOSTATIC NIPPON SHINYAKU CO., LTD. (JP) 1983-09-06 US claimed
JP-57035598-A None JP disclosed
US-20230250218-A1 URETHANE COMPOSITION NITTO KASEI CO., LTD. (JP) 2023-08-10 US disclosed
EP-4198068-A1 URETHANE COMPOSITION Nitto Kasei Co., Ltd. (JP) 2023-06-21 EP disclosed
CN-116018365-A Carbamate composition 日东化成株式会社 2023-04-25 CN disclosed
US-20180105547-A1 METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES CHILDREN'S MEDICAL CENTER CORPORATION (US) 2018-04-19 US disclosed
US-9657046-B2 Methods for the treatment and prevention of inflammatory diseases CHILDREN'S MEDICAL CENTER CORPORATION (US) 2017-05-23 US disclosed
US-20140301996-A1 METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES UNIVERSITY OF BIRMINGHAM (GB) 2014-10-09 US disclosed
EP-2575824-A2 METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES Children's Medical Center Corporation (US) 2013-04-10 EP disclosed
WO-2011149881-A2 METHODS FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY DISEASES CHILDREN'S MEDICAL CENTER CORPORATION (US) 2011-12-01 WO disclosed
EP-0869959-B1 1,7-DISUBSTITUTED PERYLENE-3,4,9,10-TETRACARBOXYLIC ACIDS AND DIANHYDRIDES AND DIIMIDES OF SAID ACIDS BASF AG (DE) 2000-05-17 EP disclosed
US-6063181-A 1,7-disubstituted perylene-3,4,9, 10-tetracarboxylic acids, their dianhydrides and diimides of said acids BASF AKTIENGESELLSCHAFT (DE) 2000-05-16 US disclosed
EP-0869959-A1 1,7-DISUBSTITUTED PERYLENE-3,4,9,10-TETRACARBOXYLIC ACIDS AND DIANHYDRIDES AND DIIMIDES OF SAID ACIDS BASF AKTIENGESELLSCHAFT (DE) 1998-10-14 EP disclosed
WO-1997022608-A1 1,7-DISUBSTITUTED PERYLENE-3,4,9,10-TETRACARBOXYLIC ACIDS AND DIANHYDRIDES AND DIIMIDES OF SAID ACIDS BASF AKTIENGESELLSCHAFT (DE) 1997-06-26 WO disclosed
US-4402948-A HEMOSTATIC NIPPON SHINYAKU CO., LTD. (JP) 1983-09-06 US disclosed
JP-S5735598-A STERYLGLUCOSIDE DERIVATIVE NIPPON SHINYAKU CO LTD 1982-02-26 JP disclosed
US-4139720-A Process for the preparation of aldehydes HOFFMANN-LA ROCHE INC. (US) 1979-02-13 US disclosed
US-4123464-A Process for the preparation of aldehydes HOFFMANN-LA ROCHE INC. (US) 1978-10-31 US disclosed
US-4073811-A Process for the preparation of aldehydes HOFFMANN-LA ROCHE INC. (US) 1978-02-14 US disclosed
US-4016212-A Process for the preparation of aldehydes HOFFMANN-LA ROCHE INC. (US) 1977-04-05 US disclosed